MetaCap

Decoy Therapeutics (DCOY) vs Propanc Biopharma (PPCB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Decoy Therapeutics is the larger company by market cap ($2.0 million vs $1.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DCOY-48.48%PPCB+256.93%
+409%+169%-70%
Oct 7, 20261 yearNov 20, 2026
DCOY-43.58%PPCB+266.48%
+317%+128%-61%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DCOY versus PPCB key metrics
MetricDCOYPPCB
Share price$0.8294$1.78
Market cap$1.98M$1.87M
1-day change-4.68%+3.19%
P/E ratio (TTM)0.03—
EPS (TTM)$31.19$-95.92
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-12.52M$-18.86M
52-week high$16.92$315.00
52-week low$0.80$1.61
Distance from 52-week high-95.10%-99.43%
Analyst consensusstrong_buy—
Avg. price target upside+261.71%—
Average volume2.17M188.66K
Shares outstanding2.39M1.05M
Employees112
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Decoy Therapeutics

DCOY stock →

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company.

Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees

About Propanc Biopharma

PPCB stock →

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

DCOY vs PPCB FAQ

Which is bigger, Decoy Therapeutics or Propanc Biopharma?

Decoy Therapeutics (DCOY) is larger, with a market capitalization of $1.98M compared with $1.87M for Propanc Biopharma (PPCB).

Are Decoy Therapeutics and Propanc Biopharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons